FDA Authorizes Updated Covid Boosters That Target Newest Variants
Published
Published
The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron..
Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron..